Trimedoxime bromide
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DMacks (talk | contribs) at 23:55, 23 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:55, 23 June 2020 by DMacks (talk | contribs) (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB))
 | |
| Clinical data | |
|---|---|
| Routes of administration | Intramuscular injection |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 2 hours (mean) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.276  |
| Chemical and physical data | |
| Formula | C15H18Br2N4O2 |
| Molar mass | 446.143 g·mol−1 |
Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning.
References
| Nervous system | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Circulatory system |
| ||||||||||||||
| Other |
| ||||||||||||||
| Emetic | |||||||||||||||
| |||||||||||||||
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |